Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/03/2010EP2244692A2 Inhalation drug products, systems and uses
11/03/2010EP2244591A1 A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent
11/03/2010EP2244577A1 Quinolizidinone m1 receptor positive allosteric modulators
11/03/2010EP2244575A1 Angiotensin ii receptor antagonists
11/03/2010EP2244574A1 Tricyclic compounds as modulators of tnf- synthesis and as pde4 inhibitors
11/03/2010EP2244572A2 Use of ibogamine congeners for treating obesity
11/03/2010EP2244571A1 Small molecule inhibitors of hiv proteases
11/03/2010EP2136807B1 Pyrrolo (3, 2, 1-ij) quinoline-4-one derivatives for treating tuberculosis
11/03/2010EP2125827B1 Azaspiro derivatives
11/03/2010EP2121678B1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/03/2010EP2121677B1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/03/2010EP2066683B1 Derivatives of 5-thioxylopyranose and use of same for treatment
11/03/2010EP2049544B1 Purinone derivatives as hm74a agonists
11/03/2010EP2046331B1 Use of 3- (4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas
11/03/2010EP2029572B1 Organic compounds
11/03/2010EP2029556B1 Salts and crystal modifications thereof
11/03/2010EP2010498B1 Synthesis of acylaminoalkenylene amides useful as substance p antagonists
11/03/2010EP1998762B1 Solid dosage form containing a taste masked active agent
11/03/2010EP1976525B1 Piperidine and piperazine derivatives
11/03/2010EP1973541B1 Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
11/03/2010EP1970372B1 Salts of 9-oxoacridine-10-acetic acid with 1-alkylamno-1-desoxy-polyols
11/03/2010EP1957088B1 Viscosupplementation with algal polysaccharides in the treatment of arthritis
11/03/2010EP1954274B1 Substituted quinolones and methods of use
11/03/2010EP1951725B1 N-sulfamoyl-n -benzopyranpiperidines as inhbitors of carbonic anhydrases
11/03/2010EP1882474B1 Prophylactic/therapeutic agent for abnormalities of lipid metabolism
11/03/2010EP1869036B1 Substituted 1,5-naphthyridine azolidinones as cdk inhibitors
11/03/2010EP1865990B1 Method of treating type-2 diabetes
11/03/2010EP1863477B1 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
11/03/2010EP1862183B1 Kit comprising drug and fat emulsion
11/03/2010EP1858910B1 Novel betulinic acid derivatives a-ring-condensed to a heterocyclic group
11/03/2010EP1855695B1 Solid pharmaceutical composition comprising telithromycin
11/03/2010EP1846406B1 Maleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
11/03/2010EP1828178B1 Process for preparation of high-purity meloxicam and meloxicam potassium salt
11/03/2010EP1805155B1 Thrombopoietin activity modulating compounds and methods
11/03/2010EP1802313B1 Therapeutic agents trageting the ncca-atp channel and methods of use thereof
11/03/2010EP1797053B1 Phenothiazinium compound for wound healing
11/03/2010EP1781667B1 Benzothienopyridines for use as inhibitors of eg5 kinesin
11/03/2010EP1781291B1 Opioids for the treatment of the restlessness of the lower limbs
11/03/2010EP1781260B1 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
11/03/2010EP1765342B1 Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for the preparation thereof
11/03/2010EP1745002B1 Novel compounds, their preparation and use
11/03/2010EP1741792B1 Novel ligand of g-protein-conjugated receptor protein and use thereof
11/03/2010EP1713798B1 C10 cyclopentyl ester substituted taxanes
11/03/2010EP1703902B1 Memantine for the treatment of mild-to-moderate alzheimer's disease
11/03/2010EP1702625B1 Medicine containing genetically modified antibody against chemokine receptor ccr4
11/03/2010EP1696825B1 Use of alginate matrices to control cell growth
11/03/2010EP1660511B1 Novel tricyclic nucleosides or nucleotides as therapeutic agents
11/03/2010EP1646622B1 Tacrine derivatives as inhibitors of acetylcholinesterase
11/03/2010EP1556080B1 Furin inhibitors for use in the treatment of fibrosis and scarring
11/03/2010EP1515966B1 Hydroxy pyranone derivative and preparation method thereof
11/03/2010EP1499742B1 Nad(p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes
11/03/2010EP1496838B1 Substituted amides
11/03/2010EP1490080B1 medical use of anthocyanins extracted from black rice
11/03/2010EP1485093B1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
11/03/2010EP1469834B1 Multi-stage oral drug controlled-release system
11/03/2010EP1467715B1 Formulations for oral administration of active compounds
11/03/2010EP1406615B1 Kinase inhibitors and the use thereof
11/03/2010EP1404302B1 Pharmaceutical compositions comprising adsorbates of amorphous drug
11/03/2010EP1296929B1 Modified forms of pharmacologically active agents and uses therefor
11/03/2010EP1292292B1 Method for treating congestive heart failure
11/03/2010EP1242437B1 Novel stromelysin inhibitors
11/03/2010EP1220838B1 1-aziridino-1-hydroxyiminomethyl-derivatives, method for the production thereof and medicaments containing said compounds
11/03/2010EP1137813B1 Method of drying a lactulose solution
11/03/2010EP0961837B1 Chimeric antisense oligonucleotides
11/03/2010EP0938320B9 Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer
11/03/2010EP0719273B1 Nucleotide analogs
11/03/2010CN1997350B Tobacco alkaloid releasing chewing gum
11/03/2010CN1980938B Mitotic kinesin inhibitors
11/03/2010CN1958074B Injectable block copolymer hydrogel of temperature sensibility(epsi - caprolactone - glycolide)- polyethyleneglycol
11/03/2010CN1951390B Pharmaceutical compositions comprising colloidal silicon dioxide
11/03/2010CN1951375B Nicotine transdermal formulation and its production method
11/03/2010CN1950370B Enantiomer-pure hexahydro- pyrrolocyclopenta- pyridine derivatives
11/03/2010CN1919251B Traditional Chinese medicine composition for treating cardiac vascular disease
11/03/2010CN1876004B A medicament for treating cerebrovascular disease
11/03/2010CN1872137B Drop pills of total glycoside of Jiaogulan, and preparation method
11/03/2010CN1872076B Drop pills of cucurbitacine, and preparation method
11/03/2010CN1872075B Drop pills of hemsleyadin, and preparation method
11/03/2010CN1872062B Fibrauretine, and preparation method
11/03/2010CN1872059B Drop pills of matrine, and preparation method
11/03/2010CN1872054B Drop pills of coumarin acetic acid, and preparation method
11/03/2010CN1872053B Drop pills of daphnetin, and preparation method
11/03/2010CN1872036B Drop pills of agrimophol, and preparation method
11/03/2010CN1857593B Cough-treating preparation
11/03/2010CN1850062B Fatty acid eye nano preparations for dry eye disease
11/03/2010CN1837198B Tanshinone IIA derivatives and pharmaceutical application thereof
11/03/2010CN1812812B Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis
11/03/2010CN1805744B New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates
11/03/2010CN1738634B Extract of stephaniae sinica diels and methods of using the same
11/03/2010CN1615295B Compounds for treatment of inflammation, diabetes and related disorders
11/03/2010CN1393438B Taxane derivative and its preparing process and usage
11/03/2010CN1310715B Polymorph of medicine
11/03/2010CN101878305A Mcp-i binding nucleic acids and use thereof
11/03/2010CN101878229A Immunoliposomes for treatment of cancer
11/03/2010CN101878221A Novel glucocorticoid receptor agonists
11/03/2010CN101878219A Imidazolothiadiazoles for use as protein kinase inhibitors
11/03/2010CN101878217A Agent for prevention and/or treatment of skin diseases
11/03/2010CN101878216A Pyrimidine derivatives as protein kinase inhibitors
11/03/2010CN101878215A Polymorphs of a C-MET/HGFR inhibitor
11/03/2010CN101878214A Benzomorphan compounds
11/03/2010CN101878213A Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes